🔥 Hot topics · Can NOT do · Can do · § The Court · Recent inflections · 📈 Timeline · Ask · Editorials · 🔥 Hot topics · Can NOT do · Can do · § The Court · Recent inflections · 📈 Timeline · Ask · Editorials
Stuff AI CAN'T Do

Can AI predict diabetes progression using retinal imaging data ?

What do you think?

Can retinal imaging alone provide a window into a patient’s future diabetes trajectory? Emerging AI models suggest that subtle vascular and structural changes in the retina may reveal early signs of diabetes progression before symptoms surface, offering a non-invasive route to preemptive care.

Background

Diabetic retinopathy is a well-known complication of diabetes, but retinal changes may also reflect broader metabolic dysfunction. AI models analyzing retinal scans could detect early signs of diabetes progression before clinical symptoms emerge. This non-invasive approach could enable proactive management of the disease.

Current AI systems can analyze retinal images to predict the onset and progression of diabetes with clinically useful accuracy. Models such as convolutional neural networks (CNNs) trained on large datasets like the UK Biobank and EyePACS can detect diabetic retinopathy and estimate related risks like future vision loss or cardiovascular events. These systems often achieve area-under-the-curve (AUC) metrics above 0.85 for predicting diabetic retinopathy progression over 1–2 years, though performance varies by population and imaging quality. Integration into clinical workflows is still limited by data standardization, regulatory approvals, and the need for longitudinal validation.

— Enriched May 12, 2026 · Source: Nature Medicine

Status last checked on June 25, 2026.

📰

Gallery

In the Court of AI Capability
Summary of Findings
Verdict over time
May 2026May 2026May 2026May 2026May 2026Jun 2026Jun 2026Jun 2026Jun 2026Jun 2026
Sitting at the Bench Filed · Jun 25, 2026
— The Question Before the Court —

Can AI predict diabetes progression using retinal imaging data?

★ The Court Finds ★
▼ Downgraded from Yes
Almost

Narrow demos exist — but the panel was not unanimous.

Ruling of the Bench

The jury found the technology promising yet still bound by the weight of real-world uncertainty, with one juror noting polished demos on curated data while another insisted nothing less than a clinic-ready tool should be declared complete. Their split landed just shy of a full acquittal, recognizing that the algorithms see what doctors fear but not yet well enough to stand alone. Ruling: "The retina reveals its secrets in pixelated whispers—let the chorus grow louder before the verdict turns.

— Hon. G. Hopper, Presiding
Jury Tally
1Yes
1Almost
0No
Verdict Confidence
88%
The Court of AI Capability is, of course, not a real court.
But the data is real.
The Case File · Stacked History
Session I · May 2026 Yes
Session II · May 2026 Almost · 80%
Session III · May 2026 Almost · 78%
Session IV · May 2026 Almost · 82%
Session V · May 2026 Almost · 79%
Session VI · Jun 2026 Almost · 73%
Session VII · Jun 2026 Almost · 77%
Session VIII · Jun 2026 Almost · 81%
Session IX · Jun 2026 Yes · 88%
Case № 1FE3 · Session X
In the Court of AI Capability

The Case File

Docket № 1FE3 · Session X · Vol. X
I. Particulars of the Case
Question put to the courtCan AI predict diabetes progression using retinal imaging data?
SessionX (10 hearing)
Convened25 Jun 2026
Previously ruledYES (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (Jun '26) → ALMOST (Jun '26) → ALMOST (Jun '26) → YES (Jun '26) → ALMOST (Jun '26)
Presiding JudgeHon. G. Hopper
II. Cumulative Tally Across Sessions

Across 10 sessions, 32 jurors have heard this case. Combined tally: 14 YES · 18 ALMOST · 0 NO · 0 IN RESEARCH.

Note: cumulative includes older juror opinions. The current session tally above is the live verdict.

III. Verdict

By a vote of 1 — 1 — 0, the panel returns a verdict of ALMOST, with verdict confidence of 88%. The court so orders. Verdict downgraded from prior session.

IV. Statements from the Bench
Juror I YES

"Specialized AI models (e.g., Google's Eye-PASS) predict diabetes progression from retinal images with high accuracy."

Juror II ALMOST

"Working demos exist for limited datasets"

G. Hopper
Presiding Judge
M. Lovelace
Clerk of the Court

What the audience thinks

No 17% · Yes 48% · Maybe 35% 23 votes
No · 17%
Yes · 48%
Maybe · 35%
50 days of activity

Discussion

no comments

Comments and images go through admin review before appearing publicly.

10 jury checks · most recent 2 days ago
25 Jun 2026 2 jurors · can, undecided undecided
20 Jun 2026 3 jurors · undecided, can, can undecided
15 Jun 2026 4 jurors · undecided, can, can, undecided undecided
09 Jun 2026 2 jurors · can, undecided undecided
04 Jun 2026 2 jurors · undecided, undecided undecided
29 May 2026 4 jurors · undecided, can, undecided, undecided undecided
24 May 2026 5 jurors · undecided, can, can, undecided, undecided undecided
19 May 2026 3 jurors · can, undecided, undecided undecided
15 May 2026 4 jurors · undecided, can, undecided, undecided undecided status changed
12 May 2026 3 jurors · can, can, can can status changed

Each row is a separate jury check. Jurors are AI models (identities kept neutral on purpose). Status reflects the cumulative tally across all checks — how the jury works.

More in health

Got one we missed?

Add a statement to the atlas. We review weekly.